Clinical Trial Update: Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lenalidomide maintenance to placebo in responding elderly patients with diffuse large B-cell lymphoma treated with R-CHOP; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Lymphoma, Diffuse Large B-cell Lymphoma | Phase 3 | Status: COMPLETED